Targeting kinases in Plasmodium and Schistosoma: Same goals, different challenges

Area of Science:

• Parasitology
• Medicinal Chemistry
• Drug Discovery

Background:

• Plasmodium spp. (malaria) and Schistosoma spp. (schistosomiasis) are major global parasitic pathogens affecting hundreds of millions.
• Existing antimalarial drugs face widespread resistance, and schistosomiasis treatment relies on a single drug, raising concerns about future resistance.
• Parasitic kinases are crucial for essential biological processes, presenting viable targets for therapeutic intervention.

Purpose of the Study:

• To highlight the critical role of kinases in the biology of Plasmodium and Schistosoma.
• To emphasize kinases as attractive targets for developing new antiparasitic compounds.
• To discuss the urgent need for novel therapeutic strategies against drug-resistant malaria and schistosomiasis.

Main Methods:

• Review of recent research on parasite biology and kinase function.
• Analysis of drug resistance patterns in malaria and schistosomiasis.
• Identification of kinases as key targets for antiparasitic drug development.

Main Results:

• Kinases regulate essential pathways in Plasmodium and Schistosoma.
• Drug resistance is a significant challenge for current malaria and schistosomiasis treatments.
• Targeting parasite kinases offers a promising avenue for novel drug discovery.

Conclusions:

• Inhibitors of protein kinases represent a vital strategy for combating malaria and schistosomiasis.
• Further research into parasite kinases is essential for developing next-generation antiparasitic therapies.
• Addressing drug resistance requires innovative approaches, with kinase inhibitors showing significant potential.